(Q37879601)

24 August 2017

1 reference

title

Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol (English)

1 reference

24 August 2017

1 reference

Takefumi Inada

1

1 reference

24 August 2017

Kozue Kubo

series ordinal

2

1 reference

24 August 2017

Koh Shingu

series ordinal

3

1 reference

24 August 2017

publication date

25 May 2011

1 reference

24 August 2017

published in

Journal of Anesthesia

1 reference

24 August 2017

volume

25

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

569-575

1 reference

Arachidonic acid metabolism

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Propofol: a review of its non-anaesthetic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Cyclooxygenase-2 in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

PGE2-induced metalloproteinase-9 is essential for dendritic cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Prostaglandin E2 regulates tumor angiogenesis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Propofol suppresses prostaglandin E(2) production in human peripheral monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E₂ production using intravenous anesthetic propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

A pathway through interferon‐γ is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Induction and mechanism of apoptotic cell death by propofol in HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Intravenous anesthetic, propofol inhibits invasion of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Suppression of Natural Killer Cell Activity and Promotion of Tumor Metastasis by Ketamine, Thiopental, and Halothane, but Not by Propofol: Mediating Mechanisms and Prophylactic Measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Enhancement of antitumor immunity after propofol treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Vaccines using dendritic cells, differentiated with propofol, enhance antitumor immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Fish consumption and breast cancer risk: an ecological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Cancer metastasis: building a framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Natural killer cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Increased surgical stress promotes tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

The influence of anaesthetic technique upon the immune response to hysterectomy. A comparison of propofol infusion and isoflurane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Effect of propofol and isoflurane anaesthesia on the immune response to surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Fatty fish consumption and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-011-1163-Y

Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines

21 January 2018

1 reference

12 December 2020

Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis

1 reference

12 December 2020

Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients

1 reference

12 December 2020

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67

1 reference

12 December 2020

Suppression of cellular immunity by surgical stress

1 reference

12 December 2020

Clinical study on total intravenous anesthesia with droperidol, fentanyl and ketamine--7. Effects on natural killer cell activity

1 reference

12 December 2020

In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.

1 reference

12 December 2020

Tumor-induced immune dysfunction: the macrophage connection.

1 reference

12 December 2020

Immunodepression after major surgery in normal patients

1 reference

12 December 2020

The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer

1 reference

12 December 2020

Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection

1 reference

12 December 2020

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

1 reference

12 December 2020

The metabolic response to stress: an overview and update

1 reference

12 December 2020

Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells

1 reference

12 December 2020

10.1007/S00540-011-1163-Y

Identifiers

DOI

1 reference

24 August 2017

1 reference